资讯

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
This drug offers 99.9% protection against HIV, but there’s a catch
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...